Skip to main content
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HIMSS 2023
  • Opinion
    • Breaking Bias
    • Commentaries
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - AI and Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Providers
April 26, 2013 12:00 AM

Feds hit Novartis with two lawsuits in a week

Joe Carlson
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print

    Novartis, the Swiss drugmaker already under a strict corporate-integrity agreement because of a past settlement, has been targeted by two lawsuits in the past week by the U.S. attorney's office for New York City that allege widespread payments of illegal kickbacks.

    One expert said the cases are so severe they may cause regulators at the HHS to try to force the removal of company executives by excluding them from working for any company that does business with Medicare.

    Federal prosecutors on Friday announced the filing of a lawsuit (PDF) alleging a widespread pattern of paying physicians in the form of lavish meals and trips and bogus speaking engagements to promote drugs. The company spent $65 million to promote hypertension drugs Lotrel and Valturna and diabetes drug Starlix.

    “In the absence of a legitimate purpose for many of the programs, the payments were nothing more than kickbacks to the doctors that induced them to write prescriptions in violation of the AKS,” or anti-kickback statute, a press release from the U.S. attorney's office says.

    The whistle-blower lawsuit was originally filed by a former Novartis employee, Oswald Bilotta, and joined by the Justice Department, 27 states and the cities of Chicago and New York.

    The announcement came just three days after the U.S. attorney's office in New York sued Novartis (PDF) for allegedly offering kickbacks disguised as rebates to pharmacists as an inducement to switch patients to its branded immunosuppressant Myofortic instead of cheaper generic drugs.

    In both cases, the company said its practices were well within accepted business practices, and it intends to argue its case in court. “As a leading healthcare company, NPC is committed to high standards of ethical business conduct and regulatory compliance in the sale and marketing of our products,” a Novartis written statement says. “It is our firm conviction that responsible business results in better business.”

    On Friday, Preet Bharara, the U.S. attorney for the Southern District of New York, said Novartis' alleged conduct was especially egregious in light of the prior corporate integrity agreement Novartis reached with the HHS inspector general's office in September 2010, an 80-page document (PDF) that stipulates strict ethics programs and requires dozens of company executives to certify the effectiveness of those efforts.

    “The widespread kickback fraud alleged in our two lawsuits against Novartis—which only a few years ago settled a False Claims Act case involving violations of the anti-kickback statute based on illegal payments to doctors—makes us question whether Novartis is getting the message,” Bharara said in a news release.

    The integrity agreement says that a “repeated or flagrant violation” of the terms gives the HHS inspector general's office the power to exclude the company from selling drugs to Medicare.

    However, former federal prosecutor Michael Clark, who now works as an attorney with the firm Duane Morris, said government officials were more likely to try to exclude Novartis executives rather than the company itself because Medicare patients likely rely on Novartis' drugs.

    “You have to balance the public policy of what happens if you exclude a company, and what happens to the drug … There are some pretty knotty issues there,” Clark said. But “people who are in a position of control at Novartis who didn't stop this from happening could be at risk of exclusion from Medicare.”

    Clark said he wasn't aware of any drug company that had ever been excluded from Medicare. However, OIG officials have made repeated statements about going after executives at pharmaceutical companies using the “responsible corporate officer doctrine,” which holds executives accountable for corporate wrong-doing, even when it can't be proven they directly oversaw it or even knew it was happening.

    In the past few years, officials at the HHS inspector general's office have excluded executives at drugmaker Purdue Pharma and devicemaker Synthes, which is today owned by Johnson & Johnson. The OIG also announced plans to exclude an executive at Forest Laboratories in 2011, but later dropped that effort without explaining why.

    Novartis, however, maintains that it did nothing wrong.

    Rebutting the case announced Friday, the company said that physician-speaker programs are a customary practice in the industry intended to inform doctors about appropriate uses of its drugs. Novartis “invests significant time and resources to help ensure these programs are conducted in an ethical and responsible manner,” the company statement said. “We are dedicated to doing it right.”

    And regarding the case filed Tuesday, the company said its rebates to pharmacies were “customary, appropriate and legal,” and that the government's legal theory was not only wrong, but could undermine discounts that government healthcare programs receive for some drugs.

    Novartis “disputes the USAO's claims in both cases and will defend itself in these litigations. We look forward to presenting the facts in these cases to the court,” the statement said.

    Follow Joe Carlson on Twitter: @MHJCarlson

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    Rob Allen Intermountain 23
    Intermountain's Graphite Health may be AI 'grounding point,' CEO says
    Nursing home wheelchair
    4,000 Michigan nursing home beds at risk in proposed staffing mandate
    Most Popular
    1
    CMS tries luring providers to revamped Medicare ACOs
    2
    Oregon joins other states in setting ratios for nurse staffing
    3
    Blue Shield CA taps Amazon, Mark Cuban, CVS for new PBM model
    4
    A health innovation hub grows in Lake Nona Medical City
    5
    Hospital-at-home providers push for Medicaid coverage
    Sponsored Content
    Modern Healthcare A.M. Newsletter: Sign up to receive a comprehensive weekday morning newsletter designed for busy healthcare executives who need the latest and most important healthcare news and analysis.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HIMSS 2023
    • Opinion
      • Breaking Bias
      • Commentaries
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - AI and Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing